Showing results (461-470 of 512) with videos related to
Sort By:
Pageof 52
Der Nervenarzt|July 13, 2019
[Diagnostics and treatment of tuberculosis under immunotherapy for multiple sclerosis : Current status and recommendations in Germany]Stefan Bittner, Sinah Engel, Christoph Lange, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 4, 2015
PML risk stratification using anti-JCV antibody index and L-selectinNicholas Schwab, Tilman Schneider-Hohendorf, Béatrice Pignolet, et al.Journal of Neuroinflammation|December 17, 2015
Investigation of sex-specific effects of apolipoprotein E on severity of EAE and MSL Schrewe, C M Lill, T Liu, et al.Der Nervenarzt|March 2, 2016
[Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action]L Klotz, A Berthele, W Brück, et al.Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 2022
Association of obesity with disease outcome in multiple sclerosisIsabel Lutfullin, Maria Eveslage, Stefan Bittner, et al.Nature Communications|December 18, 2019
IL-17+ CD8+ T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosisChristina Lückel, Felix Picard, Hartmann Raifer, et al.European Journal of Neurology|January 21, 2018
ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosisX Montalban, R Gold, A J Thompson, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2018
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosisXavier Montalban, Ralf Gold, Alan J Thompson, et al.Nature Immunology|January 20, 2015
Protein kinase CK2 enables regulatory T cells to suppress excessive TH2 responses in vivoAlexander Ulges, Matthias Klein, Sebastian Reuter, et al.Neurology(R) Neuroimmunology & Neuroinflammation|May 3, 2020
Is APOE ε4 associated with cognitive performance in early MS?Sinah Engel, Christiane Graetz, Anke Salmen, et al.Pageof 52